Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
87.3M
-
Shares change
-
-3.03M
-
Total reported value, excl. options
-
$3.63B
-
Value change
-
-$127M
-
Number of buys
-
60
-
Number of sells
-
-31
-
Price
-
$41.56
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q4 2020
123 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.3M shares
of 171M outstanding shares and own 50.99% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27.9M shares), TRV GP III, LLC (10.6M shares), FMR LLC (4.76M shares), Casdin Capital, LLC (3.81M shares), EcoR1 Capital, LLC (3.2M shares), BlackRock Inc. (3.16M shares), BVF INC/IL (3.07M shares), TRV GP IV, LLC (2.81M shares), PERCEPTIVE ADVISORS LLC (2.33M shares), and Foresite Capital Management IV, LLC (2.14M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.